DENNIS COZZENS: Open Payments
NPI 1952470676 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 26 payments from 9 companies in 2025. Trend: 2023 $1,641 · 2024 $1,450 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $147 |
| Axsome Therapeutics, Inc. | 4 | $104 |
| Lundbeck LLC | 3 | $70 |
| ABBVIE INC. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Tris Pharma Inc | 1 | $16 |
| Neuronetics, Inc. | 1 | $15 |
Products named: REXULTI, Auvelity, VRAYLAR, CAPLYTA, HETLIOZ, ABILIFY ASIMTUFII, TRINTELLIX, ABILIFY MAINTENA.
Industry payments across VA — which companies pay providers there.
